Announcement on Convening the Q3 2026 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688505)"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688505 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. on 6ix
Story so far
Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on the Resignation of Core Technical Personnel
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical